Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 4Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 6Gastrointestinal 4Head & Neck 2Tumor-Agnostic 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Gemcitabine 14Specimen Handling 12Radiotherapy 12Androgen Antagonists 12Magnetic Resonance Spectroscopy 10Nivolumab 9pembrolizumab 8Radiosurgery 8darolutamide 7Drug Therapy 7toripalimab 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Pluvicto 5Mitomycin 5Cisplatin 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Ipilimumab 4Cyclophosphamide 4Biopsy 4Axitinib 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Chemoradiotherapy × Genitourinary × Clear all
NCT07008833 2026-02-12

REDEMPTED

Brazilian Clinical Research Institute

Phase NA Not yet recruiting
336 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡